Providing market intelligence for more than 35 years

In The News

Smart thermostats are tough sell, but ComEd hopes rebates boost interest

A study released this month by Parks Associates found only 18 percent of consumers would buy a smart thermostat at $250, but offering a $100 rebate more than doubled the pool of interested buyers.

"The market for smart thermostats is still in the early adopter phase," said Tom Kerber, director of internet of things strategy for Parks Associates, a Texas-based consumer technology research and consulting company. "To move beyond early adopters, they have to offer products at a lower price point."

Kerber said prices for the first-generation smart thermostats started at about $400 but have dropped to about $250 for Nest and other leading products. He said breaking through the $150 price point opens it up to a broader market.

From the article "Smart thermostats are tough sell, but ComEd hopes rebates boost interest" by Robert Channick.

Previously In The News

The future of mobile payments – are there too many options that are confusing consumers and merchants?

“Merchants are still slowly upgrading their retail point of sale (POS) systems to support various mobile payment options while new payment options keep showing up. No merchants have provided a complet...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

TV Everywhere Usage Grows

A recent article in Multichannel News provided new findings from Parks Associates showing that 40 percent of U.S. pay TV subscribers used TV Everywhere options in 2015, up from 22 percent in 2013. "TV...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...